MBX Biosciences MBX 深 沪
等待开盘 12-19 09:30:00 美东时间
28.67
+0.970
+3.50%
华盛通- 最 高29.1899
- 今 开27.97
- 成交量 115.54万股
- 最 低 27.7701
- 昨 收 27.70
- 总市值 12.87亿
- 52周最高 34.83
- 市盈率 静 --
- 换手率 2.57%
- 52周最低 4.8069
- 委 比 20.39%
- 总股本 4490.23万
- 历史最高 34.83
- 量 比 1.94
- 振 幅 5.13%
- 历史最低 4.8069
- 每 手 1
- 风险率 6.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For December 18, 2025
Companies Reporting Before The Bell • Birkenstock Holding (NYSE:BIRK) is expect...
12-18 19:11
MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
MBX Biosciences, Inc. announced that its CEO, Kent Hawryluk, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026. The company, focused on developing precision peptide therapies for endocrine and metabolic disorders, will discuss its pipeline, including treatments for chronic hypoparathyroidism, obesity, and post-bariatric hypoglycemia. The event will be webcast and available for replay on the com...
12-15 13:00
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
12-05 08:35
Goldman Sachs Initiates Coverage On MBX Biosciences with Sell Rating, Announces Price Target of $18
Goldman Sachs analyst Corinne Johnson initiates coverage on MBX Biosciences (NASDAQ:MBX) with a Sell rating and announces Price Target of $18.
12-04 20:47
Catalyst Watch: Alibaba earnings, AI anxiety, airline M&A, and a Burry teaser
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - November ...
11-22 04:00
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference
MBX Biosciences announced that its President and CEO, Kent Hawryluk, and CMO, Sam Azoulay, will participate in the 37th Annual Piper Sandler Healthcare Conference on December 2-4 in New York. They will engage in fireside chats and 1x1 meetings during the event. The live webcast can be accessed via the Company’s website, and a replay will be available for 90 days. MBX Biosciences focuses on developing precision peptide therapies for endocrine and ...
11-18 13:00
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
MBX Biosciences Appoints Steven Hoerter as Executive Chair
MBX Biosciences, Inc. ( ($MBX) ) has shared an announcement. MBX Biosciences an...
11-06 21:28
MBX Biosciences Q3 EPS $(0.63) Beats $(0.70) Estimate
MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.70) by 9.87 percent. This is a 77.34 percent increase over losses of $(2.78) per share from the
11-06 21:14
TD Cowen Initiates Coverage On MBX Biosciences with Buy Rating
TD Cowen analyst Tyler Van Buren initiates coverage on MBX Biosciences (NASDAQ:MBX) with a Buy rating.
11-04 20:28
